EU-OPENSCREEN: A Future Pan-European Research Infrastructure for Chemical Biology; Sharing Samples, Expertise and Knowledge for the Discovery of Bioactive Small Molecules
09/14/2011
Ronald Frank | EU-OPENSCREEN | compound management | compound manager | compound integrity | European Infrastructure of Open Screening Platforms for Chemical Biology | high-throughput screening platforms | compound screening | chemical libraries | chemical resources | hit discovery | hit optimisation | cheminformatics support
Dr. Ronald Frank, Head of Research Group, Chemical Systems Biology, Leibniz- Institut fur Molekulare Pharmakologie (FMP), speaks to Pharma IQ about the EU-OPENSCREEN project initiative, funding and plans. EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high-throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening results, assay protocols, and chemical information.
Ronald Frank | EU-OPENSCREEN | compound management | compound manager | compound integrity | European Infrastructure of Open Screening Platforms for Chemical Biology | high-throughput screening platforms | compound screening | chemical libraries | chemical resources | hit discovery | hit optimisation | cheminformatics support
This interview was conducted at IQPC's 8th Compound Management & Integrity event in May 2011.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
-
Reflections on Compound Management in an Ever-Changing Organisation -
Involving Procurement Early to Maximise Value -
GSK's Peter Murray: Top Tips for Effective 3rd Party Management -
Merck Serono's Mathieu Collignon: Working with a CMO -
Developing Clinical Trials for Oncology Part 2: Outsourcing and Strategic Alliances -
Latest Advances in Compound Tracking and Distribution at Dart Neuroscience -
How to Profit from Compound Management Know-How? -
Developing Clinical Trials for Oncology Part 1: Increasing Patient Enrollment -
Case in Point: Causal Elements in the Evolution of eDiscovery -
Enhancing Viral Safety in Antibody Production Processes Using Single-Use Technologies
* = required.
Not a member yet? Sign up
Events of Interest
-
Compound Management & Integrity Online 2011
November 14, 2011
Register Now -
The Changing Face of Sample Management
January 25, 2012
Register Now -
Enhancing the Bioavailability of Low-Solubility Compounds
February 18, 2010
Register Now -
Stability Testing Training Online 2011
August 30, 2011
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!